BioNTech
BNTX
BNTX
258 hedge funds and large institutions have $5.72B invested in BioNTech in 2025 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 85 increasing their positions, 82 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
17% less call options, than puts
Call options by funds: $150M | Put options by funds: $180M
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
36% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 50
Holders
258
Holding in Top 10
4
Calls
$150M
Puts
$180M
Top Buyers
| 1 | +$355M | |
| 2 | +$88.6M | |
| 3 | +$88.4M | |
| 4 |
Bank of New York Mellon
New York
|
+$41.4M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$34M |
Top Sellers
| 1 | -$80.1M | |
| 2 | -$55M | |
| 3 | -$35.5M | |
| 4 |
Temasek Holdings
Singapore
|
-$30.4M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$29.8M |